Innovators in Corneal Strengthening
Developing the future standard of care for keratoconus and corneal ectasia
What we do
Epion Therapeutics is developing a minimally invasive treatment for ectatic corneal disease that can bring early intervention to millions of patients globally. Our EpiSmart approach is a transformative cross-linking system designed to treat keratoconus without disrupting the epithelium, allowing for a rapid return to normal activities.
